ArticleClinical case reports2025
Intrathoracic Rosai-Dorfman Disease in Elderly Patients: A Case Report.
Article in Clinical case reports, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Intrathoracic Rosai-Dorfman Disease in Elderly Patients: A Case Report.Clinical case reports · 2025Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Rosai-Dorfman disease (RDD), a rare form of histiocytosis, predominantly affects young individuals. Clinically categorized into nodal and extranodal subtypes, the disease primarily involves systemic lymph nodes with possible involvement of other organs. This variability in organ involvement leads to diverse clinical manifestations and nonspecific imaging findings, contributing to frequent diagnostic challenges and misdiagnosis. Histopathologically, the characteristic cells demonstrate S100+, CD68+, and CD1a-negative immunophenotype. We present a rare geriatric case of RDD, which may enhance diagnostic awareness and clinical management of this condition. Further research is warranted to advance our understanding of RDD pathogenesis and therapeutic strategies.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.